Perspectives: Len Lichtenberger, PhD

Perspectives is an ongoing series of Q&A’s with longtime McGovern Medical School faculty and staff, giving readers a glimpse into how the campus has changed over the years and the impact the school has had on their professional lives. This week’s edition of Perspectives features Len Lichtenberger, PhD, professor in the Department of Integrative Biology […]


Hyun-Eui Kim, Ph.D. Rising STAR brings research into cellular stress response to McGovern Medical School

A leading expert in aging-related protein misfolding diseases is bringing her research to the Department of Integrative Biology and Pharmacology at McGovern Medical School, as part of the UT Rising STARs Award program.


Ali Azhdarinia, Ph.D. Azhdarinia gets CPRIT grant for cancer research

An assistant professor in the Department of Integrative Biology and Pharmacology at McGovern Medical School is among several researchers benefiting from Cancer Prevention & Research Institute of Texas (CPRIT) grants totaling $7.4 million for investigators with The University of Texas Health Science at Houston (UTHealth).


George M. Stancel, Ph.D. Perspectives: George M. Stancel, Ph.D.

Perspectives is the first in an ongoing series of Q&A’s with longtime faculty and staff at McGovern Medical School to give readers a glimpse into how the campus has changed over the years the impact the school has had on their professional lives. This week’s edition of Perspectives features George M. Stancel, Ph.D., professor affairs in the Department Integrative Biology and Pharmacology and executive vice president of academic and research. Earlier this year, Stancel was honored with a STAR Award for his 45 years of service.


Weems to retire after 42 years of service

A retirement reception will be held Sept. 6 celebrating the career of Bill Weems, Ph.D., assistant vice president of academic technology at UTHealth, and associate dean of information and professor in the Department of Integrative Biology and Pharmacology at McGovern Medical School.


SoyLecithinStory Study: Soy lecithin NSAID combo drug protects against cancer with fewer side effects

When scientists at McGovern Medical School applied a chemical found in soybeans to a non-steroidal anti-inflammatory drug (NSAID), they increased its anticancer properties and reduced its side effects. Findings of the preclinical study of phosphatidylcholine, also called lecithin, appear in the journal Oncology Letters.


Dr. Ruth Heidelberger McGovern Medical School professors showcase research at Biophysical Society Annual Meeting

Professors from several departments at McGovern Medical School shared research presentations with thousands of scientists in biophysics at the 62nd Annual Meeting of the Biophysical Society (BPS) earlier this year.


Dr. Gary Rosenfeld accepted the Merrell Flair Award in Medical Education in November. Rosenfeld honored with Merrell Flair Award

Dr. Gary Rosenfeld, professor of pharmacology and associate dean of Medical Education in the Department of Integrative Biology and Pharmacology, received the Merrell Flair Award in Medical Education last month at the Association of American Medical Colleges (AAMC) Annual Meeting in Boston.


Working to further the understanding of cancer-induced muscle wasting at McGovern Medical School at UTHealth are Yi-Ping Li, Ph.D., left, and Guohua Zhang, Ph.D. UTHealth scientists block cancer-induced muscle wasting in preclinical study

The discovery of proteins that initiate the muscle wasting caused by tumors could lead to new treatments for this hard-to-treat and often fatal condition called cancer-induced cachexia or cancer cachexia, report scientists with the McGovern Medical School in a proof-of-concept study in the journal Nature Communications.